Definitive agreement to acquire all outstanding shares of implant manufacturer
SALZBURG, AUSTRIA, AND YORK, PENNSYLVANIA—On Monday, Dentsply Sirona announced a definitive agreement to acquire all of the outstanding shares of privately held MIS Implants Technologies Ltd., a dental implant systems manufacturer headquartered in Barlev, Israel.
“MIS is uniquely positioned to address the value segment of the implant market in both its home region and around the globe," said Jeffrey T. Slovin, Chief Executive Officer of Dentsply Sirona. "It is strategically important to be able to address the implant market with distinct organizations, portfolios, and brands, targeting both the premium and value segments. MIS has a broad portfolio of implants and related products under a well-established brand, making it a great complement to our company.”
The agreement opens up many new opportunities of growth and services for both parties, which benefits customers and patients around the globe.
RELATED: Robert W. Baird & Co's take on the Dentsply-Sirona merger and the 5 key dental themes of 2015
A Young, Innovative Company
MIS was founded in 1995 in Shlomi, Israel. The company has a strong presence in the value segment, selling its products in more than 65 countries worldwide. MIS ("Make It Simple") aims to simplify implant dentistry through innovation and clinical education. The MIS brand offers a wide range of dental implants and prosthetic solutions, together with grafting materials and guided surgery services.
MIS launched its latest innovation with the V3 implant system last year in June at the EuroPerio8 in London. It is patented for its unique triangular shape and brings biological benefits in many different aspects. The V3 design allows for greater volume of bone and soft tissue, reduces pressure on the cortical bone, and does not compromise primary stability.
High Quality Standards Across All Implant Lines and Brands
Dentsply Sirona develops and produces innovations in the areas of implant surface technologies, implant-abutment connections, immediate placement protocols, and guided surgery. Products such as Ankylos, Astra Tech Implant Systems, and XiVE rank among the leading implant systems. The addition of the MIS, a leading value implant company, will extend the range of therapy concepts to additional market segments.
Source: Dentsply Sirona press release 27 June 2015
